Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate.

Nieder AM, Carmack AJ, Sved PD, Kim SS, Manoharan M, Soloway MS.

Urology. 2005 Apr;65(4):730-4.

PMID:
15833517
[PubMed - indexed for MEDLINE]
2.

Intraoperative cell salvage during radical cystectomy does not affect long-term survival.

Nieder AM, Manoharan M, Yang Y, Soloway MS.

Urology. 2007 May;69(5):881-4.

PMID:
17482926
[PubMed - indexed for MEDLINE]
3.

The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence?

Davis M, Sofer M, Gomez-Marin O, Bruck D, Soloway MS.

BJU Int. 2003 Apr;91(6):474-6.

PMID:
12656896
[PubMed - indexed for MEDLINE]
4.

Effect of perioperative blood transfusion on prostate cancer recurrence.

Ford BS, Sharma S, Rezaishiraz H, Huben RS, Mohler JL.

Urol Oncol. 2008 Jul-Aug;26(4):364-7. doi: 10.1016/j.urolonc.2007.06.004. Epub 2007 Nov 7.

PMID:
18367097
[PubMed - indexed for MEDLINE]
5.

Intraoperative cell salvage in radical retropubic prostatectomy.

Gray CL, Amling CL, Polston GR, Powell CR, Kane CJ.

Urology. 2001 Nov;58(5):740-5.

PMID:
11711352
[PubMed - indexed for MEDLINE]
6.

Oncologic outcomes following radical prostatectomy with intraoperative cell salvage.

Gorin MA, Eldefrawy A, Manoharan M, Soloway MS.

World J Urol. 2012 Jun;30(3):379-83. doi: 10.1007/s00345-011-0746-4. Epub 2011 Aug 17.

PMID:
21847657
[PubMed - indexed for MEDLINE]
7.

Impact of patient age on biochemical recurrence rates following radical prostatectomy.

Magheli A, Rais-Bahrami S, Humphreys EB, Peck HJ, Trock BJ, Gonzalgo ML.

J Urol. 2007 Nov;178(5):1933-7; discussion 1937-8. Epub 2007 Sep 17.

PMID:
17868723
[PubMed - indexed for MEDLINE]
8.

Intraoperative cell salvage during radical prostatectomy: a safe technique for Jehovah's Witnesses.

Nieder AM, Simon MA, Kim SS, Manoharan M, Soloway MS.

Int Braz J Urol. 2004 Sep-Oct;30(5):377-9.

PMID:
15610568
[PubMed - indexed for MEDLINE]
Free Article
9.

A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.

Smith JA Jr, Chan RC, Chang SS, Herrell SD, Clark PE, Baumgartner R, Cookson MS.

J Urol. 2007 Dec;178(6):2385-9; discussion 2389-90. Epub 2007 Oct 22.

PMID:
17936849
[PubMed - indexed for MEDLINE]
10.

Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins.

Simon MA, Kim S, Soloway MS.

J Urol. 2006 Jan;175(1):140-4; discussion 144-5.

PMID:
16406892
[PubMed - indexed for MEDLINE]
11.

Impact of intraoperative red blood cell salvage on transfusion requirements and outcomes in radical prostatectomy.

MacIvor D, Nelson J, Triulzi D.

Transfusion. 2009 Jul;49(7):1431-4. doi: 10.1111/j.1537-2995.2009.02131.x. Epub 2009 Mar 20.

PMID:
19320863
[PubMed - indexed for MEDLINE]
12.

Does wide primary perirectal dissection during radical retropubic prostatectomy alter pathologic and biochemical outcomes?

Dussinger AM, Beck SD, Cheng L, Koch MO.

Urology. 2005 Nov;66(5 Suppl):95-100.

PMID:
16194713
[PubMed - indexed for MEDLINE]
13.

Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortality.

Raval JS, Nelson JB, Woldemichael E, Triulzi DJ.

Transfusion. 2012 Dec;52(12):2590-3. doi: 10.1111/j.1537-2995.2012.03682.x. Epub 2012 May 21.

PMID:
22612661
[PubMed - indexed for MEDLINE]
14.

Predicting blood loss and transfusion requirements during radical prostatectomy: the significant negative impact of increasing body mass index.

Chang SS, Duong DT, Wells N, Cole EE, Smith JA Jr, Cookson MS.

J Urol. 2004 May;171(5):1861-5.

PMID:
15076294
[PubMed - indexed for MEDLINE]
15.

Prognostic value of surgical margin status for biochemical recurrence following radical prostatectomy.

Hashimoto K, Masumori N, Takei F, Fukuta F, Takahashi A, Itoh N, Hasegawa T, Tsukamoto T.

Jpn J Clin Oncol. 2008 Jan;38(1):31-5. doi: 10.1093/jjco/hym135. Epub 2008 Jan 17.

PMID:
18203710
[PubMed - indexed for MEDLINE]
Free Article
16.

Benefit on biochemical control of adjuvant radiation therapy in patients with pathologically involved seminal vesicles after radical prostatectomy.

Greco C, Castiglioni S, Fodor A, De Cobelli O, Longaretti N, Rocco B, Vavassori A, Orecchia R.

Tumori. 2007 Sep-Oct;93(5):445-51.

PMID:
18038876
[PubMed - indexed for MEDLINE]
17.

Comparison of prostate-specific antigen recurrence-free survival in a contemporary cohort of patients undergoing either radical retropubic or robot-assisted laparoscopic radical prostatectomy.

Schroeck FR, Sun L, Freedland SJ, Albala DM, Mouraviev V, Polascik TJ, Moul JW.

BJU Int. 2008 Jul;102(1):28-32. doi: 10.1111/j.1464-410X.2008.07607.x. Epub 2008 Apr 2.

PMID:
18384634
[PubMed - indexed for MEDLINE]
18.

Salvage radiation therapy for prostate specific antigen progression following radical prostatectomy: 10-year outcome estimates.

Pazona JF, Han M, Hawkins SA, Roehl KA, Catalona WJ.

J Urol. 2005 Oct;174(4 Pt 1):1282-6.

PMID:
16145393
[PubMed - indexed for MEDLINE]
19.

Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?

Haukaas SA, Halvorsen OJ, Daehlin L, Hostmark J, Akslen LA.

BJU Int. 2006 Jan;97(1):51-5.

PMID:
16336328
[PubMed - indexed for MEDLINE]
20.

Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.

Delongchamps NB, Zerbib M, Mejean A, Rouach Y, Debre B, Peyromaure M.

Can J Urol. 2009 Oct;16(5):4813-9.

PMID:
19796456
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk